Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001474506-25-000065
Filing Date
2025-03-28
Accepted
2025-03-28 20:31:22
Documents
2
Period of Report
2024-07-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2946
2 POWER OF ATTORNEY poa_ballantynetrust.txt EX-24 3446
  Complete submission text file 0001474506-25-000065.txt   8247
Mailing Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070
Business Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070 972 (8) 675-7878
Glucotrack, Inc. (Issuer) CIK: 0001506983 (see all company filings)

EIN.: 980668934 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 301 ROUTE 17 NORTH, SUITE 800 RUTHERFORD NJ 07070
Business Address 301 ROUTE 17 NORTH, SUITE 800 RUTHERFORD NJ 07070 2018427715
John A. Ballantyne Revocable Living Trust dated 08/01/2017 (Reporting) CIK: 0002046615 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41141 | Film No.: 25788403